Bausch & Lomb Pharmaceutical, Inc.

FDA Regulatory Profile

Bausch & Lomb Pharmaceutical, Inc. appears in FDA public data with 0 recalls, 6 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on February 9, 1990.

Summary

Total Recalls
0
510(k) Clearances
6
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K884962ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEAFebruary 9, 1990
K884960ADDIT. INDICATION FOR FYODOROV COLLAGEN CORNEALFebruary 13, 1989
K884961ADDIT. INDICATIONS FOR BIO-COR II COLLAGEN CORNEALFebruary 13, 1989
K884362LABELING CHANGES TO FYODOROV COLLAGEN CORNEAL SHLDNovember 29, 1988
K884363LABELING CHANGES TO BIO-COR II COLLANGEN CORNEALNovember 29, 1988
K884364LABELING CHANGES TO BIO-COR EXT COLLANGEN CORNEALNovember 29, 1988